从阳性血培养和血样本直接诊断血流感染的分子方法最新进展
血流感染发病率和严重程度不断上升,血培养仍是微生物诊断参考标准但较慢。分子方法可作为补充检测,用于阳性血培养或直接血样本,加速微生物鉴定和抗菌药物敏感性预测。本文综述了用于血流感染诊断的分子诊断平台最新进展,聚焦直接血样本和阳性血培养的检测。
要点
- 血培养仍是血流感染微生物诊断的参考标准,但速度较慢。
- 分子方法可作为补充检测,加速微生物鉴定和耐药预测。
- 直接血样本和阳性血培养均可应用分子诊断平台。
核心结论
- 分子方法作为传统血培养诊断和抗菌药物管理规划的补充,可能通过快速鉴定病原体和相关耐药基因来优化感染管理。
- 快速诊断致病微生物和相关耐药决定因子对于早期给药和调整适当抗菌治疗很重要,最终可能改善医疗质量和成本效益并减少抗菌药物耐药选择。
研究设计与样本
- 综述,检索同行评议文章、会议摘要和制造商网站。
主要发现
- 阳性血培养可用的分子方法包括:原位杂交方法、DNA微阵列杂交技术、核酸扩增方法以及联合方法。
- 直接应用于全血样本的分子方法包括核酸扩增方法、T2磁共振方法和宏基因组学用于血流感染诊断。
临床怎么用
- 分子方法可作为传统血培养诊断的补充,并与抗菌药物管理规划结合,以优化感染管理。
- 快速诊断致病微生物和相关耐药决定因子对于早期给药和调整适当抗菌治疗很重要。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Bloodstream infections are a major cause of death with increasing incidence and severity. Blood cultures are still the reference standard for microbiological diagnosis, but are rather slow. Molecular methods can be used as add-on complementary assays. They can be useful to speed up microbial identification and to predict antimicrobial susceptibility, applied to direct blood samples or positive blood cultures. AIM: To review recent developments in molecular-based diagnostic platforms used for the identification of bloodstream infections, with a focus on assays performed directly on blood samples and positive blood cultures. SOURCES: Peer reviewed articles, conference abstracts, and manufacturers' websites. CONTENT: We give an update on recent developments of molecular methods in diagnosing BSIs. We first describe the currently available molecular methods to be used for positive blood cultures including: a) in situ hybridization-based methods; b) DNA-microarray-based hybridization technology; c) nucleic acid amplification-based methods; and d) combined methods. Subsequently, molecular methods applied directly to whole blood samples are discussed, including the use of nucleic acid amplification-based methods, T2 magnetic resonance-based methods, and metagenomics for diagnosing BSIs. IMPLICATIONS: Advances in molecular-based methods complementary to conventional blood culture diagnostics and antimicrobial stewardship programmes may optimize infection management by allowing rapid identification of pathogens and relevant antimicrobial resistance genes. Rapid diagnosis of the causing microorganism and relevant resistance determinants is important for early administration and modification of appropriate antimicrobial therapy. Ultimately, this may lead to improved quality and cost-effectiveness of health care, as well as reduced antimicrobial resistance selection.
引用
- Peker N, Couto N, Sinha B, et al. Diagnosis of bloodstream infections from positive blood cultures and directly from blood samples: recent developments in molecular approaches. Clin Microbiol Infect. 2018. PMID: 29787889. doi:10.1016/j.cmi.2018.05.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。